By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Stemline Therapeutics, Inc. 

1675 York Avenue
Suite 30-E
New York  New York  10128  U.S.A.
Phone: 212-831-1111 Fax:


SEARCH JOBS








Company News
Stemline Therapeutics, Inc. (STML) Announces Proposed Public Offering Of Common Stock 1/8/2015 7:54:20 AM
Stemline Therapeutics, Inc. (STML) In-Licenses Novel Oral Small Molecule Nuclear Transport Inhibitor Targeting XPO1 1/8/2015 7:53:23 AM
Stemline Therapeutics, Inc. (STML) Prices $59.85 Million Public Offering Of Common Stock 1/8/2015 7:44:33 AM
Stemline Therapeutics, Inc. (STML) To Present At The 33rd Annual J.P. Morgan Healthcare Conference 12/29/2014 7:24:07 AM
Stemline Therapeutics, Inc. (STML) Initiates SL-401 Clinical Trial In Four Rare Myeloproliferative Neoplasms 12/17/2014 7:29:19 AM
Stemline Therapeutics, Inc. (STML) Announces Multiple Preclinical Presentations Highlighting Its Pipeline Of IL-3R-Directed Therapeutics At The American Society of Hematology Annual Meeting 12/5/2014 12:15:21 PM
Stemline Therapeutics, Inc. (STML) Reports Third Quarter 2014 Financial Results And Provides Corporate Update 11/12/2014 8:03:28 AM
Stemline Therapeutics, Inc. (STML) To Participate In The Barclays Select Series Symposium 11/10/2014 10:14:09 AM
Stemline Therapeutics, Inc. (STML) Initiates SL-401 Trial In AML Patients In First Complete Response With Minimal Residual Disease, The Second SL-401 Trial Initiated In 2H14 10/16/2014 7:38:20 AM
Stemline Therapeutics, Inc. (STML) To Present At The Aegis Capital 2014 Healthcare & Technology Conference 9/8/2014 7:55:56 AM
12345678
//-->